Anthony Johnson
On May 22, 2025, Anthony Johnson, a Director of the Company, provided written notice to the Company that he is resigning effective July 15, 2025.
Highest-materiality recent filing
Received 180-day termination notice from Smoker Friendly International, LLC for Master Services Agreement dated Jan 1, 2025.
22nd Century Group shareholders elect Lucille Salhany, approve comp, ratify auditor
Elected Lucille Salhany as Class III director with 1,163,869 for, 34,794 withheld; no broker non-votes.
22nd Century Group files 1-for-20 reverse stock split, raises ~$463K in warrant inducement
1-for-20 reverse stock split effective June 12, 2026 to regain NASDAQ compliance; outstanding shares to fall from ~10.3M to ~516k.
22nd Century Group Announces Warrant Inducement and 1-for-20 Reverse Stock Split
Commenced warrant inducement offering with holders of existing warrants for up to 5,345,591 shares.
Q1 2026: net rev $4.1M (-31% YoY); zero debt; VLN now in 2,000+ stores
Net revenues $4.1M, down 31.1% YoY from $5.96M; net loss from continuing ops $3.0M improved from $3.3M.
22nd Century Group registers $6.4M common stock ATM offering with Needham & Co.
Filed prospectus supplement under S-3 to sell up to $6.4M in common stock via ATM program.
22nd Century Q4 2025 net rev $3.5M, net loss $2.8M; exits year debt-free with $7.1M cash
Q4 net revenues $3.5M, down 12% YoY; gross loss improved to $(0.8)M from $(1.3)M.
Initial close of $16.0M of Series B Preferred at $1,000 stated value; additional $4M possible within one year.
Preliminary Q4 2025 net revenue $3.6M vs $4.0M in Q3; FY2025 revenue $17.6M vs $24.4M in 2024.
22nd Century Group files 1-for-15 reverse stock split to regain NASDAQ listing compliance
Reverse stock split ratio is 1-for-15, effective at 12:01 a.m. ET on January 26, 2026.
Extends Stockholder Approval Deadline from 90 days post-closing to February 23, 2026.
Net revenue $4.0M, down 32.5% YoY; gross loss widened to $1.1M from $0.6M in prior quarter.
22nd Century settles insurance claim for $9.5M cash; company now debt-free
Settlement resolves all business-interruption claims from Nov 2022 Grass Valley fire; insurer pays $9.5M within 45 days.
22nd Century repays $3.9M senior secured debt, becomes debt-free
Repaid $3.9M outstanding under JGB SPA and terminated all related debentures and liens on Sept 18, 2025.
22nd Century Group replaces auditor Freed Maxick with WithumSmith+Brown effective Aug 22, 2025
Audit Committee approved replacement of Freed Maxick P.C. due to acquisition of certain assets by WithumSmith+Brown, PC.
22nd Century Group raises $10.65M in Series A Preferred and Warrants offering
$10.65M offering of Series A Convertible Preferred Stock (stated value $1,000/share) and 5-year warrants to buy common at $1.97/share.
22nd Century Q2 revenue falls 48.6% to $4.1M; operating loss widens
Net revenues $4.1M, down 48.6% YoY from $7.9M and sequentially from $6.0M.
22nd Century shareholders approve doubling authorized shares and reverse split authorization
Shareholders approved doubling authorized common shares from 250M to 500M.
22nd Century expands Pinnacle deal with top-5 c-store chain; exclusive manufacturing for 5 years
Exclusive 5-year manufacturing deal for Pinnacle cigarettes and moist snuff brands with top-5 c-store chain.
Reverse stock split at 1:23 ratio, effective 12:01 a.m. ET on June 20, 2025.
22nd Century Group amends JGB debentures allowing conversion price reset; director resigns
Amended JGB debentures: one-time reset of conversion price to 5-day VWAP average, not exceeding $6.04; $3.8M outstanding.
Net revenues $6.0M, up ~50% from $4.0M in Q4 2024; gross loss improved to $(0.6)M from $(1.3)M.
22nd Century Group launches warrant inducement, expects up to $8.8M proceeds
Offered holders of 11,072,093 existing warrants ($4.3021 exercise) to exercise at reduced price of $0.7893, with 100% warrant coverage.
Settlement resolves derivative actions alleging breach of fiduciary duties over a stock promotion scheme and false statements.
22nd Century reports Q4 net loss of $4.2M; launches VLN partner brands for Q2 2025
Net revenue $4.0M in Q4 2024, down 32% from $5.9M in Q3 2024; FY 2024 revenue $24.4M vs $32.2M in FY 2023.
22nd Century regains Nasdaq minimum bid price compliance, avoids delisting
Received Nasdaq letter on Jan 21, 2025 confirming compliance with Listing Rule 5550(a)(2).
22nd Century Group Resets Conversion Price on Senior Secured Credit Facility to $6.04 per Share
On January 13, 2025, the Board of Directors approved resetting the Conversion Price to $6.04 per share.
Exclusive license and manufacturing agreement for 5 years, covering 11 existing SF brands and 8 new premium brands.
Nasdaq determines to delist XXII; company appeals, completes 1-for-135 reverse split
Nasdaq notified 22nd Century on Dec 16, 2024 that stock had bid price ≤$0.10 for 10 consecutive days, triggering Low Priced Stocks Rule and delisting.
22nd Century shareholders approve reverse stock split up to 1:250 and warrant issuances
Reverse stock split authorized at ratio between 1:2 and 1:250 to comply with Nasdaq listing rules.
22nd Century Q3 revenues $5.9M, net loss $3.6M; targets cash positive by Q1 2025
Net revenues $5.9M, down 24.5% YoY; gross loss $(0.6)M vs $0.1M profit YoY.
22nd Century Group raises ~$3M via PIPE of prefunded warrants and warrants
Sold 28,354,914 prefunded warrants at $0.10719 each and 42,532,372 common warrants exercisable at $1.00, expiring 5 years after stockholder approval.
22nd Century Group raises ~$2.1M in registered direct offering with warrants
Gross proceeds ~$2.1M from 14.3M shares at $0.15/share and warrants for 28.5M shares.
One-time reset of Conversion Price to 5-day average VWAP, not above current $0.7458, subject to Holder written approval.
22nd Century Group regains Nasdaq stockholders' equity compliance; raised $11.6M in equity
Received Nasdaq notice confirming compliance with minimum $2.5M stockholders' equity requirement under Rule 5550(b)(1).
22nd Century Group raises ~$1.2M via registered direct offering and warrant inducement
Sold 5,153,508 shares and warrants for 10,307,016 shares at $0.228 per unit; gross proceeds ~$1.2M.
22nd Century Group believes it now meets Nasdaq minimum equity requirement of $2.5M
Issued 1.15M shares to extinguish subordinated debt, increasing equity by $3.9M.
22nd Century raises $3.48M in Reg A offering and issues 12.2M warrants
Sold 6.1M shares at $0.57/share for gross proceeds of $3.48M under Regulation A; total sold in offering is 9.72M shares.
22nd Century agrees $1.22M IP payment with NCSU, payable in cash or stock
Total payment of $1,220,438 to NCSU covers IP licensing, royalties, and sponsored research through 2025.
22nd Century raises $1.68M via Reg A offering, amends JGB debenture terms
Issued 2.95M shares at $0.57/share for $1.68M gross proceeds under Reg A; total sold 3.62M shares.
No material news; 22nd Century Group announces virtual investor conference participation.
Press release dated August 20, 2024 announces participation in Emerging Growth Virtual Conference on August 21, 2024.
22nd Century Group sells 460K shares at $0.57 for $262K gross; may raise up to $6M more
Issued 460,000 shares at $0.57/share for gross proceeds of $262,200 to an institutional investor.
22nd Century Q2 net loss narrows to $2.2M; targets cash positive by Q1 2025
Net revenues $7.9M, up 22.8% sequentially; net loss $2.2M, improved 61.4% from Q1 2024.
22nd Century Group appoints Robert Manfredonia as EVP of Sales and Marketing
Robert Manfredonia appointed EVP of Sales and Marketing, effective August 1, 2024.
22nd Century Group receives Nasdaq deficiency notice for bid price below $1.00
Nasdaq notified company on July 16, 2024 that stock failed to meet $1.00 minimum bid price for 30 consecutive business days.
Stockholders voted against declassifying the Board of Directors (685,689 for, 69,180 against, with 1,595,154 broker non-votes).
22nd Century reduces secured debt by $1.5M via GVB payment; total now $8.3M
GVB Biopharma paid $1.5M directly to lender JGB, cutting total secured principal to $8.3M.
Nasdaq grants 22nd Century 180-day extension to regain equity compliance by Oct 1, 2024
Stockholders' equity deficit of ($8,410,000) as of Dec 31, 2023, is below Nasdaq's $2,500,000 minimum.
President of Tobacco John Miller resigns effective August 2, 2024
John Miller, President of Tobacco at 22nd Century Group, gave notice of resignation on May 27, 2024.
22nd Century Group Q1 2024 net loss $5.5M; improves from prior year; reduces debt by $8M in Q2
Net revenue from continuing ops $6.5M; gross profit negative $1.1M including $0.4M inventory reserves and $0.2M excise tax.
On May 22, 2025, Anthony Johnson, a Director of the Company, provided written notice to the Company that he is resigning effective July 15, 2025.
On July 30, 2024, the Company appointed Robert Manfredonia as its Executive Vice President of Sales and Marketing, effective August 1, 2024.
On May 27, 2024, John Miller, the President of Tobacco for 22 nd Century Group, Inc. (the “Compay”), provided notice that he is resigning from such position effective August 2, 2024.
On April 18, 2024, James Mish, a Director of the Company, provided written notice to the Company that he is resigning effective immediately.
On April 18, 2024, Nora B. Sullivan, a Director of 22 nd Century Group, Inc. (the “Company”), provided written notice to the Company that she is resigning effective immediately.
On April 6, 2024, the Board of Directors of the Company approved the appointment of Daniel Otto as its Chief Financial Officer, effective immediately.
On April 6, 2024, Hugh Kinsman, the Company’s Chief Financial Officer, provided notice that he is resigning from such position effective June 1, 2024.
On April 6, 2024, the Board of Directors also appointed Jonathan Staffeldt as the Company’s General Counsel effective immediately.
On December 21, 2023, Peter Ferola, the Chief Legal Officer and Corporate Secretary of 22nd Century Group, Inc., was terminated effective immediately.
On November 28, 2023, the Board appointed Lawrence D. Firestone as Chairman of the Board of Directors (“ Board ”), expanding the Board to eight directors, and as the Company’s Chief Executive Officer
at which time, Mr. John Miller, the Company’s interim Chief Executive Officer, will resume the position of President of the Tobacco Business.
the Board appointed John J. Miller, who has served as President of the Tobacco Business since November 2022, as interim-CEO of the Company effective immediately.
Max materiality 0.90 · Median 0.65 · Most common event other_material